| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +109K | 58.1% | $5.27 | +$574K |
| Sells | 1 | -78.5K | 41.9% | $10.17 | -$798K |
| Net | +1 | +30.5K | 16.3% | -$224K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Biotech Growth N V | 10%+ Owner | $78.9M | Oct 26, 2022 | ||
| Franklin M. Berger | Director | $7.85M | +$553K | +7.58% | Mar 25, 2024 |
| Bvf Partners L P/Il | 10%+ Owner | $3.58M | Jul 11, 2022 | ||
| David Parkinson | Chief Executive Officer, Director | $657K | +$21.2K | +3.33% | Mar 25, 2024 |
| Scott Requadt | Director | $300K | Mar 25, 2024 | ||
| Richard M. Glickman | Director | $212K | Apr 24, 2024 | ||
| Peter Virsik | Chief Operating Officer | $78.2K | -$798K | -91.1% | May 6, 2024 |
| Marella Thorell | Director | Mar 25, 2024 | |||
| Sanford Zweifach | Director | Mar 25, 2024 | |||
| Alessandra Cesano | Chief Medical Officer | Mar 25, 2024 | |||
| John Alexander Martin | Director | Mar 25, 2024 | |||
| David Wood | Chief Financial Officer | Mar 25, 2024 | |||
| Philip W. Kantoff | Director | Mar 25, 2024 | |||
| Lauren Merendino | Director | Mar 25, 2024 | |||
| Gary Sollis | Director | Mar 25, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|